Barclays Maintains Underweight on Clorox, Raises Price Target to $118
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman has maintained an Underweight rating on Clorox (NYSE:CLX) but increased the price target from $115 to $118.

January 16, 2024 | 5:14 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays has maintained an Underweight rating on Clorox but raised the price target from $115 to $118, indicating a cautious but slightly more optimistic outlook.
The increase in price target by Barclays suggests a modestly improved outlook for Clorox, which could be taken positively by the market. However, the Underweight rating indicates that Barclays still has concerns about the company's prospects. The mixed signals may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100